Skip to main content

Monsanto's misery

The GM giant scales down its plans for growth in Europe in the face of public opposition to its products.

Written byPat Hagan
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

The full scale of public opposition in Europe to genetically-modified crops has been highlighted by US corporation Monsanto's announcement that it's likely to be at least another three years before if can win approval there for its GM products.

Hendrik Verfaillie, the company's chief executive, said in an interview with the Financial Times that such is the resistance to GM crops that it is now assuming there will be no progress in Europe until 2005 at the earliest.

"We are trying to be conservative," he was reported as saying. "It is better to under-promise than under-deliver."

The company has already conceded that profits this year will be a third lower than it originally hoped for. The more bearish outlook follows hard on the heels of the latest GM crop debacle in the UK. The Department for the Environment, Food and Rural Affairs has ordered an investigation after it emerged that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems
Optimizing NGS Library Preparation for Reliable Sequencing Data

Optimizing NGS Library Preparation for Reliable Sequencing Data

Covaris
Using TCR Repertoire Sequencing to Advance Immunology Research

Using TCR Repertoire Sequencing to Advance Immunology Research

Miltenyi
Mapping Clonal Mosaicism in Aging Tissues

Mapping Clonal Mosaicism in Aging Tissues

Mission bio

Products

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo
Conceptual image of ice and frost.

The VAULT100 PRO: Inside the most advanced Stirling Ultracold ULT freezer ever built.

Stirling Ultracold logo